Skip to main content
Log in

Hybrid Therapy with Right Atrial Catheter Ablation and Previously Ineffective Antiarrhythmic Drugs for the Management of Atrial Fibrillation

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Background: Many patients with paroxysmal atrial fibrillation (AF) become refractory to antiarrhythmic drugs (AADs). Early studies suggested that linear catheter ablation in the right atrium may provide sufficient substrate modification to reestablish therapeutic efficacy of previously ineffective AADs.

Methods: This prospective before-after multicenter trial evaluated the safety and effectiveness of hybrid therapy that included right atrial catheter ablation coupled with a regimen of previously ineffective AADs on AF episode frequency and symptoms in drug refractory patients with paroxysmal AF. A standard linear lesion set (lateral, septal, isthmus) was used in all subjects. AF episode frequency, clinical arrhythmia symptoms, condition-specific (AFSS) and global health-related quality of life (SF-36) were assessed prior to ablation and at 6 months.

Results: Ninety-three subjects, refractory to an average 2.9 AADs at baseline, qualified for inclusion and underwent right atrial catheter ablation. Eighty-four subjects (90%) provided 6 month AF episode frequency data which demonstrated a significant decrease compared to baseline (3.4 vs. 9.5, p < 0.0001). Forty-nine subjects (58%) were considered a clinical success by virtue of achieving a pre-specified target level episode frequency reduction of 50% or greater. Substantial and statistically significant improvements were realized almost uniformly for all measured arrhythmia symptoms as well as for both quality of life measures. The incidence of major complications was 5.4%.

Conclusions: The addition of right atrial catheter ablation to a regimen of previously ineffective AADs is associated with a significant reduction in the frequency, duration and severity of AF episodes and symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Narayan SM, Cain ME, Smith JM. Atrial fibrillation. Lancet1997;350:943–950.

    Article  CAS  PubMed  Google Scholar 

  2. Cox JL, Schuessler RB, Lappas DG, Boineau JP. An 8 1/2-year clinical experience with surgery for atrial fibrillation. Ann Surg1996;224:267–273; discussion 273– 265.

    Article  CAS  PubMed  Google Scholar 

  3. Lonnerholm S, Blomstrom P, Nilsson L, Oxelbark S, Jideus L, Blomstrom-Lundqvist C. Effects of the maze operation on health-related quality of life in patients with atrial fibrillation. Circulation2000;101:2607–2611.

    CAS  PubMed  Google Scholar 

  4. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Klein WW, Alonso-Garcia A, Blomstrom-Lundqvist C, De Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A; American College of Cardiology/American Heart Association/European Society of Cardiology Board. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol2001;38:1231–1266.

    Article  CAS  PubMed  Google Scholar 

  5. Israel CW, Gronefeld G, Ehrlich JR, Li YG, Hohnloser SH. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: Implications for optimal patient care. J Am Coll Cardiol2004;43:47– 52.

    Article  PubMed  Google Scholar 

  6. Snow V, Weiss KB, LeFevre M, McNamara R, Bass E, Green LA, Michl K, Owens DK, Susman J, Allen DI, Mottur-Pilson C; AAFP Panel on Atrial Fibrillation; ACP Panel on Atrial Fibrillation. Management of newly detected atrial fibrillation: A clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med2003;139:1009–1017.

    PubMed  Google Scholar 

  7. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med2002;347:1825–1833.

    CAS  PubMed  Google Scholar 

  8. Keane D, Zhou L, Ruskin J. Catheter ablation for atrial fibrillation. Semin Interv Cardiol1997;2:251–265.

    CAS  PubMed  Google Scholar 

  9. Keane D, Zou L, Ruskin J. Nonpharmacologic therapies for atrial fibrillation. Am J Cardiol1998;81:41C– 45C.

    Article  CAS  PubMed  Google Scholar 

  10. Ng FS, Camm AJ. Catheter ablation of atrial fibrillation. Clin Cardiol2002;25:384–394.

    Article  PubMed  Google Scholar 

  11. Adam M, Fischetti D, Montenero AS. A typical pattern of activation in the right atrium during paroxysmal atrial fibrillation: The washing-machine phenomenon. Cardiol 1999;44:63–68.

    CAS  Google Scholar 

  12. Allessie MA, Konings K, Kirchhof CJ, Wijffels M. Electrophysiologic mechanisms of perpetuation of atrial fibrillation. Am J Cardiol1996;77:10A–23A.

    Article  CAS  PubMed  Google Scholar 

  13. Nair M, Shah P, Batra R, Kumar M, Mohan J, Kaul U, Arora R. Chronic atrial fibrillation in patients with rheumatic heart disease: Mapping and radiofrequency ablation of flutter circuits seen at initiation after cardioversion. Circulation2001;104:802–809.

    CAS  PubMed  Google Scholar 

  14. Schmitt C, Ndrepepa G, Weber S, Schmieder S, Weyerbrock S, Schneider M, Karch MR, Deisenhofer I, Schreieck J, Zrenner B, Schomig A. Biatrial multisite mapping of atrial premature complexes triggering onset of atrial fibrillation. Am J Cardiol2002;89:1381–1387.

    Article  PubMed  Google Scholar 

  15. Saksena S, Prakash A, Krol RB, Shankar A. Regional endocardial mapping of spontaneous and induced atrial fibrillation in patients with heart disease and refractory atrial fibrillation. Am J Cardiol1999;84:880–889.

    Article  CAS  PubMed  Google Scholar 

  16. Jais P, Weerasooriya R, Shah DC, Hocini M, Macle L, Choi KJ, Scavee C, Haissaguerre M, Clementy J. Ablation therapy for atrial fibrillation (AF): Past, present and future. Cardiovasc Res2002;54:337–346.

    Article  CAS  PubMed  Google Scholar 

  17. Calkins H, Hall J, Ellenbogen K, Walcott G, Sherman M, Bowe W, Simpson J, Castellano T, Kay GN. A new system for catheter ablation of atrial fibrillation. Am J Cardiol1999;83:227D–236D.

    CAS  PubMed  Google Scholar 

  18. Kocheril AG. Right atrial mapping and linear ablation for paroxysmal atrial fibrillation. J Interv Card Electrophysiol2001;5:505–510.

    Article  CAS  PubMed  Google Scholar 

  19. Murgatroyd FD. “Pills and pulses”: Hybrid therapy for atrial fibrillation. J Cardiovasc Electrophysiol2002;13:S40–S46.

    PubMed  Google Scholar 

  20. Santini M, Pignalberi C, Ricci R, Calo L. Hybrid therapy of atrial fibrillation. Ital Heart J2002;3:571–578.

    PubMed  Google Scholar 

  21. Block JE, Kocheril A. Right atrial ablation in the management of atrial fibrillation: Point of view. J Interv Card Electrophysiol2004;16.

  22. Jumrussirikul P, Atiga WL, Lardo AC, Berger RD, Halperin H, Hutchins GM, Calkins H. Prospective comparison of lesions created using a multipolar microcatheter ablation system with those created using a pullback approach with standard radiofrequency ablation in the canine atrium. Pacing Clin Electrophysiol2000;23:203–213.

    CAS  PubMed  Google Scholar 

  23. Kocheril A. Revelation(R) Tx Microcatheter Maze Procedure Successfully Treats Paroxysmal AF. Pacing Clin Electrophysiol2003;26:1566.

    Google Scholar 

  24. Ware JE, Jr., Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol1998;51:903–912.

    PubMed  Google Scholar 

  25. Ware JE, Jr., Snow KK, Kosinski M, Gandek B. Validity: Norm-based interpretation. SF-36 Health Survey Manual and Interpretation Guide. Vol 10. Lincoln, RI: Quality Metric, Inc.; 2000:4–10.

  26. Braunwald E. Shattuck lecture–cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities. N Engl J Med1997;337:1360–1369.

    CAS  PubMed  Google Scholar 

  27. Gaita F, Riccardi R, Calo L, Scaglione M, Garberoglio L, Antolini R, Kirchner M, Lamberti F, Richiardi E. Atrial mapping and radiofrequency catheter ablation in patients with idiopathic atrial fibrillation. Electrophysiological findings and ablation results. Circulation1998;97:2136–2145.

    CAS  PubMed  Google Scholar 

  28. Garg A, Finneran W, Mollerus M, Birgersdotter-Green U, Fujimura O, Tone L, Feld GK. Right atrial compartmentalization using radiofrequency catheter ablation for management of patients with refractory atrial fibrillation. J Cardiovasc Electrophysiol1999;10:763–771.

    CAS  PubMed  Google Scholar 

  29. Calo L, Lamberti F, Loricchio ML, Castro A, Shpun S, Boggi A, Pandozi C, Santini M. Long-term follow-up of right atrial ablation in patients with atrial fibrillation. J Cardiovasc Electrophysiol2004;15:37–43.

    PubMed  Google Scholar 

  30. Montenero AS, Quayyum A, Franciosa P, Mangiameli D, Antonelli A, Barbieri L, Bruno N, Zumbo F, Vimercati M. Implantable loop recorders: A novel method to judge patient perception of atrial fibrillation. Preliminary results from a pilot study. J Interv Card Electrophysiol2004;10:211–220.

    PubMed  Google Scholar 

  31. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Jama1995;273:408–412.

    CAS  PubMed  Google Scholar 

  32. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med2000;342:1878–1886.

    Article  CAS  PubMed  Google Scholar 

  33. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med2000;342:1887–1892.

    Article  CAS  PubMed  Google Scholar 

  34. Bouchet C, Guillemin F, Briancon S. Nonspecific effects in longitudinal studies: Impact on quality of life measures. J Clin Epidemiol1996;49:15–20.

    CAS  PubMed  Google Scholar 

  35. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagne P, Nattel S, Thibault B. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med2000;342:913–920.

    CAS  PubMed  Google Scholar 

  36. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med1998;339:659–666.

    Article  CAS  PubMed  Google Scholar 

  37. Arentz T, von Rosenthal J, Blum T, Stockinger J, Burkle G, Weber R, Jander N, Neumann FJ, Kalusche D. Feasibility and safety of pulmonary vein isolation using a new mapping and navigation system in patients with refractory atrial fibrillation. Circulation2003;108:2484–2490.

    PubMed  Google Scholar 

  38. Ernst S, Ouyang F, Lober F, Antz M, Kuck KH. Catheter-induced linear lesions in the left atrium in patients with atrial fibrillation: An electroanatomic study. J Am Coll Cardiol2003;42:1271–1282.

    PubMed  Google Scholar 

  39. Nanthakumar K, Plumb VJ, Epstein AE, Veenhuyzen GD, Link D, Kay GN. Resumption of electrical conduction in previously isolated pulmonary veins: Rationale for a different strategy? Circulation2004;109:1226–1229.

    PubMed  Google Scholar 

  40. Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G, Salvati A, Dicandia C, Mazzone P, Santinelli V, Gulletta S, Chierchia S. Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation2000;102:2619–2628.

    CAS  PubMed  Google Scholar 

  41. Pappone C, Oreto G, Rosanio S, Vicedomini G, Tocchi M, Gugliotta F, Salvati A, Dicandia C, Calabro MP, Mazzone P, Ficarra E, Di Gioia C, Gulletta S, Nardi S, Santinelli V, Benussi S, Alfieri O. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: Efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation2001;104:2539–2544.

    CAS  PubMed  Google Scholar 

  42. Gerstenfeld EP, Guerra P, Sparks PB, Hattori K, Lesh MD. Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers. J Cardiovasc Electrophysiol2001;12:900–908.

    CAS  PubMed  Google Scholar 

  43. Jais P, Shah DC, Hocini M, Yamane T, Haissaguerre M, Clementy J. Radiofrequency catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol2000;11:758– 761.

    CAS  PubMed  Google Scholar 

  44. Yu WC, Hsu TL, Tai CT, Tsai CF, Hsieh MH, Lin WS, Lin YK, Tsao HM, Ding YA, Chang MS, Chen SA. Acquired pulmonary vein stenosis after radiofrequency catheter ablation of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol2001;12:887–892.

    CAS  PubMed  Google Scholar 

  45. Kok LC, Mangrum JM, Haines DE, Mounsey JP. Cerebrovascular complication associated with pulmonary vein ablation. J Cardiovasc Electrophysiol2002;13:764–767.

    PubMed  Google Scholar 

  46. Saad EB, Rossillo A, Saad CP, Martin DO, Bhargava M, Erciyes D, Bash D, Williams-Andrews M, Beheiry S, Marrouche NF, Adams J, Pisano E, Fanelli R, Potenza D, Raviele A, Bonso A, Themistoclakis S, Brachmann J, Saliba WI, Schweikert RA, Natale A. Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: Functional characterization, evolution, and influence of the ablation strategy. Circulation2003;108:3102– 3107.

    PubMed  Google Scholar 

  47. Arentz T, Jander N, von Rosenthal J, Blum T, Furmaier R, Gornandt L, Josef Neumann F, Kalusche D. Incidence of pulmonary vein stenosis 2 years after radiofrequency catheter ablation of refractory atrial fibrillation. Eur Heart J2003;24:963–969.

    PubMed  Google Scholar 

  48. Pappone C, Oral H, Santinelli V, Vicedomini G, Lang CC, Manguso F, Torracca L, Benussi S, Alfieri O, Hong R, Lau W, Hirata K, Shikuma N, Hall B, Morady F. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation2004;109:2724–2726.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abraham G. Kocheril MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kocheril, A.G., Calkins, H., Sharma, A.D. et al. Hybrid Therapy with Right Atrial Catheter Ablation and Previously Ineffective Antiarrhythmic Drugs for the Management of Atrial Fibrillation. J Interv Card Electrophysiol 12, 189–197 (2005). https://doi.org/10.1007/s10840-005-0620-7

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-005-0620-7

Keywords

Navigation